American Foundation for Urologic Disease website. Available at:
. Accessed July 19, 2008.
Controlling urinary incontinence. FDA Consumer Magazine, United States Food and Drug Administration website. Available at:
. Published September-October 2005. Accessed July 19, 2008.
Corcos J, Gajewski J, Heritz D, et al. Canadian Urological Association guidelines on urinary incontinence.
Can J Urol
Norton P, Brubaker L. Urinary incontinence in women.
Overactive bladder. American Urological Association Foundation website. Available at:
. Updated July 2009. Accessed October 31, 2009.
Overactive bladder treatment. National Association for Continence website. Available at:
. Updated July 2009. Accessed November 2, 2009.
Sobhgol SS, Charandabee SM. Related factors of urge, stress, mixed urinary incontinence, and overactive bladder in reproductive age women in Tabriz, Iran: a cross-sectional study.
Int Urogynecol J Pelvic Floor Dys Function
Surgical management of urinary incontinence. American Urological Association Foundation website. Available at:
. Updated September 2003. Accessed October 31, 2009.
Urinary incontinence in women.
National Institute of Diabetes and Digestive and Kidney Diseases website. Available at:
. Published October 2007. Accessed July 19, 2008.
Wein A, ed.
9th ed. Philadelphia, PA: Saunders, Elsevier; 2007.
Wein AJ, Rackley RR. Overactive bladder: a better understanding of pathophysiology, diagnosis, and management.
2/5/2009 DynaMed's Systematic Literature Surveillance
: Subak L, Wing R, Smith West D, et al. Weight loss to treat urinary incontinence in overweight and obese women.
N Engl J Med.
1/11/2010 DynaMed's Systematic Literature Surveillance
DynaMed's Systematic Literature Surveillance: AHRQ evidence report on treatment for overactive bladder in women 2009. Agency for Healthcare Research and Quality website. Available at: http://www.ahrq.gov/clinic/tp/bladdertp.htm. Published August 2009. Accessed January 11, 2010.
3/5/2010 DynaMed's Systematic Literature Surveillance
DynaMed's Systematic Literature Surveillance: Vardy MD, Mitcheson HD, Samuels TA, et al. Effects of solifenacin on overactive bladder symptoms, symptom bother and other patient-reported outcomes: results from VIBRANT—a double-blind, placebo-controlled trial. Int J Clin Pract. 2009;63(12):1702-1714.
Please be aware that this information is provided to supplement the care
provided by your physician. It is neither intended nor implied to be a
substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER
IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the
advice of your physician or other qualified health provider prior to
starting any new treatment or with any questions you may have regarding a
Copyright © 2007
EBSCO Publishing All rights reserved.